P3.02a-016 Pooled Efficacy and Safety Data from Two Phase II Studies (NP28673 and NP28761) of Alectinib in ALK+ Non-Small-Cell Lung Cancer (NSCLC)

著录项

• 来源
  《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第1期|共2页
• 作者

  James Chih-Hsin Yang; Sai-Hong Ou; Luigi De Petris; Shirish Gadgeel; Leena Gandhi; Dong-Wan Kim; Fabrice Barlesi; Ramaswamy Govindan; Anne-Marie Dingemans; Lucio Crinò; Hervé Léna; Sanjay Popat; Jin Seok Ahn; Eric Dansin; Sophie Golding; Walter Bordogna; Bogdana Balas; Peter N. Morcos; Ali Zeaiter; Alice Shaw;

  展开▼
• 作者单位

  Graduate Institute of Oncology National Taiwan University;

  Chao Family Comprehensive Cancer Centre University of California Irvine School of Medicine;

  Oncology Karolinska University Hospital;

  Karmanos Cancer Institute;

  Dana-Farber Cancer Institute;

  Seoul National University Hospital;

  Aix-Marseille University Assistance Publique H?pitaux de Marseille;

  Department of Internal Medicine Washington University School of Medicine;

  Pulmonary Diseases Maastricht University Medical Centre;

  Perugia University Hospital;

  Centre Hospitalier Universitaire de Rennes;

  Royal Marsden Hospital;

  Samsung Medical Center;

  Clcc Oscar-Lambret;

  F. Hoffmann-La Roche Ltd;

  F. Hoffmann-La Roche Ltd;

  F. Hoffmann-La Roche Ltd;

  Roche;

  F. Hoffmann-La Roche Ltd;

  Massachusetts General Hospital Cancer Center;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词